LYKALABSPharmaceuticals

Lyka Labs LtdFinancial Ratios & Key Metrics

44.95
-9.04%
P/E Ratio139.58xIndustry: 31.77x
ROE9.31%Return on equity
ROCE9.91%Return on capital
Debt/Equity0.31Low debt
💎

Valuation & Profitability

P/E Ratio
139.58x
Industry Average P/E
31.77x
Dividend Yield
0.00%
Market Cap
₹284.75 (Cr)
Sales Growth 5Y
17.63%
Profit Growth 5Y
17.89%
EPS Growth 5Y
17.32%
OPM 5Y Avg
27.50%
📉

Price Returns

1 Month
-14.54%
3 Months
-20.36%
6 Months
-31.26%
1 Year
-48.99%
52W Low
46
Current
45
52W High
129
-1% of 52-week range — Near lows
🔬

Technical Indicators

29RSI 14
Oversold
Selling pressure is heavy — potential reversal zone.
SMA 50
65
▼ Price below SMA 50 — Bearish
SMA 200
89
▼ Long-term downtrend
Volume Signal
168% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.